Salt Lake City Utah based Recursion Pharmaceuticals is raising $235,506,731.00 in New Equity Investment.
Salt Lake City, UT – According to filings with the U.S. Securities and Exchange Commission, Recursion Pharmaceuticals is raising $235,506,731.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Christopher Gibson…